SEC Filings

Form 424B5
KERYX BIOPHARMACEUTICALS INC filed this Form 424B5 on 07/27/2017
Document Outline
Entire Document (382.1 KB)
Subdocument 1 - 424B5 - 424B5
Page 1 - Filed Pursuant to Rule 424(b)(5)
Page 2 - TABLE OF CONTENTS
Page 3 - ABOUT THIS PROSPECTUS SUPPLEMENT
Page 4 - PROSPECTUS SUPPLEMENT SUMMARY
Page 5 - Journal of the American Society of Nephrology
Page 6 - THE OFFERING
Page 7 - N/A
Page 8 - RISK FACTORS
Page 9 - We have not paid dividends in the past and do not expect to pay dividends in the future on our commo
Page 10 - SPECIAL NOTE REGARDING FORWARD-LOOKING STATEMENTS
Page 11 - USE OF PROCEEDS
Page 12 - DILUTION
Page 13 - N/A
Page 14 - PLAN OF DISTRIBUTION
Page 15 - LEGAL MATTERS
Page 16 - INCORPORATION OF DOCUMENTS BY REFERENCE
Page 17 - N/A
Page 18 - PROSPECTUS
Page 19 - TABLE OF CONTENTS
Page 20 - ABOUT THIS PROSPECTUS
Page 21 - PROSPECTUS SUMMARY
Page 22 - Additional Information
Page 23 - This prospectus may not be used to consummate a sale of any securities unless it is accompanied by a
Page 24 - RISK FACTORS
Page 25 - RATIO OF EARNINGS TO FIXED CHARGES
Page 26 - SPECIAL NOTE REGARDING FORWARD-LOOKING STATEMENTS
Page 27 - USE OF PROCEEDS
Page 28 - PLAN OF DISTRIBUTION
Page 29 - N/A
Page 30 - DESCRIPTION OF COMMON STOCK
Page 31 - DESCRIPTION OF PREFERRED STOCK
Page 32 - Transfer Agent and Registrar
Page 33 - DESCRIPTION OF DEBT SECURITIES
Page 34 - Conversion or Exchange Rights
Page 35 - N/A
Page 36 - Modification of Indenture; Waiver
Page 37 - Discharge
Page 38 - Information Concerning the Debenture Trustee
Page 39 - DESCRIPTION OF WARRANTS
Page 40 - DESCRIPTION OF RIGHTS
Page 41 - Rights Agent
Page 42 - DESCRIPTION OF PURCHASE CONTRACTS
Page 43 - DESCRIPTION OF UNITS
Page 44 - Enforceability of Rights by Holders of Units
Page 45 - CERTAIN PROVISIONS OF DELAWARE LAW AND OF THE COMPANY S CERTIFICATE OF INCORPORATION AND BYLAWS
Page 46 - Limitations on Liability and Indemnification of Officers and Directors
Page 47 - LEGAL MATTERS
Page 48 - INCORPORATION OF DOCUMENTS BY REFERENCE
Page 49 - N/A
Page 50 - Up to $75,000,000